SCHEMBL400213

SCHEMBL400213

CCOC(=O)CCc1ccc(N)c(C(=O)N(C)C)c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP4F2 P78329 2/20 0.51
CYP4A11 Q02928 2/20 0.51
CYP4Z1 Q86W10 1/20 0.42
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
P2RY12 Q9H244 1/20 0.41
ALDH1A1 P00352 4/20 0.40
HSD17B10 Q99714 2/20 0.40
GAA P10253 2/20 0.40
KDM4E B2RXH2 1/20 0.40
MAPT P10636 1/20 0.40
HPGD P15428 1/20 0.40
ALOX15 P16050 1/20 0.40
TSHR P16473 1/20 0.40
APP P05067 1/20 0.40
MAP4K1 Q92918 4/20 0.39
ABL1 P00519 1/20 0.38
CYP3A4 P08684 1/20 0.38
CDC25B P30305 1/20 0.38
CASP6 P55212 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3732157 0.86 ALDH1A1 (0.49) ALDH1A1HSD17B10GAAKDM4EMAPT
SCHEMBL3862461 0.82 CYP4F2 (0.61) CYP4F2CYP4A11CYP4Z1PDE3BPDE3A
SCHEMBL7456664 0.82 CYP4F2 (0.51) CYP4F2CYP4A11CYP4Z1PDE3BPDE3A
SCHEMBL13263723 0.80 CYP4F2 (0.59) CYP4F2CYP4A11CYP4Z1PDE3BPDE3A
SCHEMBL397878 0.80 CYP4F2 (0.47) CYP4F2CYP4A11CYP4Z1PDE3BPDE3A
SCHEMBL5274836 0.79 CYP4F2 (0.58) CYP4F2CYP4A11CYP4Z1PDE3BPDE3A
Hydrochloric Acid SCHEMBL6986041 0.79 CYP4F2 (0.58) CYP4F2CYP4A11CYP4Z1PDE3BPDE3A
Hydrochloric Acid SCHEMBL27590314 0.78 CYP4F2 (0.54) CYP4F2CYP4A11CYP4Z1PDE3BPDE3A
SCHEMBL400412 0.78 ALOX5 (0.42) ALDH1A1HSD17B10KDM4EHPGDTSHR
SCHEMBL11247614 0.78 CYP4F2 (0.56) CYP4F2CYP4A11CYP4Z1PDE3BPDE3A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8101774-B2 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2012-01-24 US disclosed
EP-1803452-A1 ESTER DERIVATIVE AND PHARMACEUTICAL USE THEREOF Japan Tobacco, Inc. (JP) 2007-07-04 EP disclosed
US-20060089392-A1 Ester derivatives and medicinal use thereof JAPAN TOBACCO INC. (JP) 2006-04-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060089392-A1 Ester derivatives and medicinal use thereof MTTP, CETP, LIPA CYP4F2 97/4885CYP4A11 162/4885CYP4Z1 511/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.